Teva Pharmaceutical
TEVA
$0.16 (-0.95%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
InvestorPlace • 12 days ago • TEVA
Patent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeBusiness Wire • 13 days ago • TEVA
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global OperationsSeeking Alpha • 14 days ago • TEVA
Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)Zacks Investment Research • 15 days ago • TEVA
Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?MarketBeat • 18 days ago • TEVA
These 7 Stocks Surged Double-Digits and Have Double-Digits to GoCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.